Treatment with insulin detemir provides improved glycaemic control and less weight gain compared to NPH insulin in people with diabetes

被引：0
|
作者：
Garber, AJ
Kim, H
Draeger, E
机构：
[1] Baylor Coll Med, Dept Med, Endocrinol Sect, Houston, TX 77030 USA
[2] Novo Nordisk AS, Clin Stat, Gladsaxe, Denmark
[3] Novo Nordisk AS, Reg Europe, Med Affairs NNRE, CDC Europe, Zurich, Switzerland
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
150
引用
收藏
页码：A58 / A58
页数：1
相关论文
共 50 条
  • [31] Insulin Detemir vs. NPH: Association with Maternal Weight Gain in Pregnancy
    Herrera, Kimberly
    Rosenn, Barak
    Foroutan, Janelle
    Bimson, Brianne
    Al-Ibraheemi, Zainab
    Scarpelli, Sophia
    Brustman, Lois
    [J]. DIABETES, 2015, 64 : A675 - A675
  • [32] Improved glycaemic control and reduced nocturnal hypoglycaemia in patients with Type 2 diabetes with morning administration of insulin glargine compared with NPH insulin
    Fritsche, A
    Schweitzer, MA
    Häring, H
    [J]. DIABETOLOGIA, 2002, 45 : A52 - A52
  • [33] Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes
    Haak, T
    Tiengo, A
    Draeger, E
    Suntum, M
    Waldhäusl, W
    [J]. DIABETES OBESITY & METABOLISM, 2005, 7 (01): : 56 - 64
  • [34] Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes
    Kolendorf, K.
    Ross, G. P.
    Pavlic-Renar, I.
    Perriello, G.
    Philotheou, A.
    Jendle, J.
    Gall, M-A.
    Heller, S. R.
    [J]. DIABETIC MEDICINE, 2006, 23 (07) : 729 - 735
  • [35] Decreased hypoglycaemic episodes and less weight gain in patients with Type 1 diabetes transferred from NPH to insulin glargine with maintenance of glycaemic control despite lower insulin doses
    Gottlieb, R
    Garg, S
    Paul, J
    Chase, P
    Menditto, L
    [J]. DIABETOLOGIA, 2004, 47 : A304 - A304
  • [36] Improved Glycemic Control and Weight Loss in Slovskian Patients Switching from NPH to Insulin Detemir
    Martinka, Emil
    Lacka, Jozef
    [J]. DIABETES, 2009, 58 : A527 - A527
  • [37] Maternal glycaemic control and hypoglycaemia in pregnancy: a randomised trial comparing insulin detemir with NPH insulin in 310 subjects with type 1 diabetes
    Mathiesen, E. R.
    Damm, P.
    Hod, M.
    McCance, D. R.
    Ivanisevic, M.
    Garcia, S.
    Jovanovic, L.
    [J]. DIABETOLOGIA, 2011, 54 : S486 - S487
  • [38] Cerebral glucose metabolism in human type 1 diabetes is increased after treatment with insulin detemir compared to NPH insulin: possible explanation for differences in weight?
    van Golen, L. W.
    Huisman, M. C.
    Ijzerman, R. G.
    Hoetjes, N. J.
    Schwarte, L. A.
    Schober, P.
    Hoogma, R. P.
    Drent, M. L.
    Lammertsma, A. A.
    Diamant, M.
    [J]. DIABETOLOGIA, 2011, 54 : S287 - S288
  • [39] Insulin detemir achieves lower, less variable fasting glucose and a reduced risk of nocturnal hypoglycaemia and weight gain compared to NPH insulin in basal bolus therapy of Japanese patients with type 1 diabetes
    Kobayashi, M.
    Iwamoto, Y.
    Kawamori, R.
    Tajima, N.
    Nishida, T.
    Kaku, K.
    [J]. DIABETOLOGIA, 2006, 49 : 608 - 609
  • [40] Insulin detemir is associated with less weight gain than NPH insulin, especially in the very obese, when used in basal bolus therapy for patients with type 2 diabetes
    Raslova, K
    Karl, D
    Tamer, SC
    [J]. DIABETOLOGIA, 2005, 48 : A306 - A306
12345